Logo.jpg
ProPhase Labs Announces Record Second Quarter 2022 Financial Results
August 11, 2022 08:00 ET | ProPhase Labs, Inc.
Record Q2 2022 Net Revenues of $29.1 Million; Up 218% Year-over-Year Record Q2 2022 Net Income of $7.4 Million; Up 633% Year-over-Year Management to Host Conference Call Today at 11:00...
Logo.jpg
ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time
August 04, 2022 20:33 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on...
Logo.jpg
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
July 26, 2022 08:00 ET | ProPhase Labs, Inc.
Company also provides additional information on ProPhase BioPharma Garden City, NY, July 26, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a rapidly growing and...
Logo.jpg
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2022 18:00 ET | ProPhase Labs, Inc.
Garden City, NY, July 21, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it has granted an inducement stock option...
Logo.jpg
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
July 21, 2022 08:30 ET | ProPhase Labs, Inc.
Confirms Quarterly Growth continues year-over-year Announces significant progress being made in Genomics Business Company to Host Live Webcast to Discuss Business Developments Today at 11:30...
Logo.jpg
ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022
July 19, 2022 08:30 ET | ProPhase Labs, Inc.
Garden City, NY, July 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday,...
Logo.jpg
ProPhase Labs Announces Significant Laboratory Expansion
June 13, 2022 08:30 ET | ProPhase Labs, Inc.
Expanding in-house clinical testing capabilities Initiates plans to build new genomics laboratory Garden City, NY, June 13, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a...
Logo.jpg
ProPhase Labs Announces Record First Quarter 2022 Financial Results
May 13, 2022 08:30 ET | ProPhase Labs, Inc.
Record Net Revenues of $47.5 Million, Up 211% Year-over-Year Record Net Income of $12.5 Million, Increasing 1082% Year-over-Year Announces Special Cash Dividend of $0.30 per...
Logo.jpg
ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor Conference
May 11, 2022 18:25 ET | ProPhase Labs, Inc.
Garden City, NY, May 11, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present at...
Logo.jpg
ProPhase Labs Announces Appointment of Bill White as Chief Financial Officer
May 10, 2022 08:15 ET | ProPhase Labs, Inc.
Garden City, NY, May 10, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified diagnostics and genomics company, announced today that Bill White has been appointed Chief...